HUTCHMED (China) Limited (HCM)

USD 15.0

(1.35%)

Long Term Debt Summary of HUTCHMED (China) Limited

  • HUTCHMED (China) Limited's latest annual long term debt in 2023 was 48.18 Million USD , up 106.82% from previous year.
  • HUTCHMED (China) Limited's latest quarterly long term debt in 2024 Q2 was 55.63 Million USD , down 0.0% from previous quarter.
  • HUTCHMED (China) Limited reported annual long term debt of 23.3 Million USD in 2022, up 225.37% from previous year.
  • HUTCHMED (China) Limited reported annual long term debt of 7.16 Million USD in 2021, down -78.25% from previous year.
  • HUTCHMED (China) Limited reported quarterly long term debt of 55.63 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • HUTCHMED (China) Limited reported quarterly long term debt of 51.04 Million USD for 2023 Q3, up 27.16% from previous quarter.

Annual Long Term Debt Chart of HUTCHMED (China) Limited (2023 - 2005)

Historical Annual Long Term Debt of HUTCHMED (China) Limited (2023 - 2005)

Year Long Term Debt Long Term Debt Growth
2023 48.18 Million USD 106.82%
2022 23.3 Million USD 225.37%
2021 7.16 Million USD -78.25%
2020 32.92 Million USD 10.24%
2019 29.86 Million USD 11.7%
2018 26.73 Million USD 4518.13%
2017 579 Thousand USD -97.84%
2016 26.83 Million USD -0.35%
2015 26.92 Million USD 0.0%
2014 26.92 Million USD 0.0%
2013 - USD -100.0%
2012 26.92 Million USD 0.0%
2011 - USD 0.0%
2010 - USD -100.0%
2009 145.52 Thousand USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%

Peer Long Term Debt Comparison of HUTCHMED (China) Limited

Name Long Term Debt Long Term Debt Difference
Esperion Therapeutics, Inc. 501.54 Million USD 90.392%
Theratechnologies Inc. 51.26 Million USD 5.993%
Safety Shot Inc 304.9 Thousand USD -15704.491%
Cosmos Health Inc. 3.03 Million USD -1487.598%
Cronos Group Inc. 1.55 Million USD -2991.02%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 90.329%
Kala Pharmaceuticals, Inc. 34.19 Million USD -40.945%
Organogenesis Holdings Inc. 60.74 Million USD 20.67%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD -369.77%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -55289.655%
Dynavax Technologies Corporation 252.41 Million USD 80.909%
Radius Health, Inc. 339.66 Million USD 85.813%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -41041.818%
Alvotech 1.02 Billion USD 95.311%
Sunshine Biopharma, Inc. 539.03 Thousand USD -8839.865%
Alpha Teknova, Inc. 13.25 Million USD -263.663%
Intra-Cellular Therapies, Inc. 13.32 Million USD -261.616%
SCYNEXIS, Inc. 12.15 Million USD -296.324%
Harrow Health, Inc. 183.17 Million USD 73.692%
Biofrontera Inc. 804 Thousand USD -5893.657%
DURECT Corporation 2.7 Million USD -1683.457%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -45.165%
ANI Pharmaceuticals, Inc. 309.66 Million USD 84.439%
OptiNose, Inc. 611 Thousand USD -7786.907%
RedHill Biopharma Ltd. 455 Thousand USD -10490.989%
Aquestive Therapeutics, Inc. 91.07 Million USD 47.089%
Cumberland Pharmaceuticals Inc. 12.78 Million USD -276.944%
SIGA Technologies, Inc. 335.99 Thousand USD -14242.348%
Lifecore Biomedical, Inc. 120.51 Million USD 60.012%
Shineco, Inc. 10.01 Million USD -381.056%
Phibro Animal Health Corporation 458.28 Million USD 89.485%
Procaps Group S.A. 28.41 Million USD -69.62%
TherapeuticsMD, Inc. 6.53 Million USD -637.737%
Regencell Bioscience Holdings Limited - USD -Infinity%
Viatris Inc. 16.18 Billion USD 99.702%
Sunshine Biopharma, Inc. 539.03 Thousand USD -8839.865%
Rockwell Medical, Inc. 8.29 Million USD -481.08%
Incannex Healthcare Limited 210 Thousand USD -22847.143%
Aytu BioPharma, Inc. 10.87 Million USD -343.036%
Tilray Brands, Inc. 287.93 Million USD 83.264%
Collegium Pharmaceutical, Inc. 489.96 Million USD 90.165%
PetIQ, Inc. 437.82 Million USD 88.993%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 258.3 Million USD 81.344%
Journey Medical Corporation 14.62 Million USD -229.565%
Alimera Sciences, Inc. 64.48 Million USD 25.276%
Petros Pharmaceuticals, Inc. 6.85 Million USD -602.734%
Assertio Holdings, Inc. 38.51 Million USD -25.121%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -35572.038%
Embecta Corp. 1.62 Billion USD 97.035%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -214225.743%
Procaps Group, S.A. 28.41 Million USD -69.62%
PainReform Ltd. 30 Thousand USD -160530.0%
Avadel Pharmaceuticals plc 32.75 Million USD -47.097%
Hempacco Co., Inc. 5.93 Million USD -712.494%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 513.79 Million USD 90.621%
Alvotech 1.02 Billion USD 95.311%
Lantheus Holdings, Inc. 616.12 Million USD 92.179%
Kamada Ltd. 7.43 Million USD -547.876%
Indivior PLC 235.66 Million USD 79.552%
Currenc Group, Inc. 2.5 Million USD -1822.198%
Evoke Pharma, Inc. 5 Million USD -863.78%
Flora Growth Corp. 942 Thousand USD -5015.605%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -214225.743%
Evolus, Inc. 120.35 Million USD 59.962%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 91.821%
Akanda Corp. 2.49 Million USD -1829.756%